Companies / LENZ Therapeutics, Inc. / Activity

Activity — LENZ Therapeutics, Inc.

14 moves.

Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
InsidersInstitutions
DateActorActionSecurityValueShares ΔPosition afterImpact
Mar 27, 2026Schimmelpennink Evert B.
CEO
BuyCommon Stock$251.4K+28K
+57.09%
77,289
0.25% of shares
medium
Mar 27, 2026Chevallard Daniel R.
Executive
BuyCommon Stock$64.3K+8K
+139.25%
12,886
0.04% of shares
medium
Mar 27, 2026George Jeffrey P.
Director
BuyCommon Stock$49.9K+6K
5,592
0.02% of shares
low
Jun 15, 2026Drapkin Kimberlee C
Director
GrantStock Option (right to buy)—+22K
22,100
0.07% of shares
low
Jun 15, 2026RA Capital Management, L.P.
Director
GrantStock Option (right to buy)—+22K
22,100
0.07% of shares
low
Jun 15, 2026Thunen Shelley B
Director
GrantStock Option (right to buy)—+22K
22,100
0.07% of shares
low
Jun 15, 2026McCollum James W
Director
GrantStock Option (right to buy)—+22K
22,100
0.07% of shares
low
Jan 2, 2026Odrich Marc
Executive
GrantRestricted Stock Unit—+14K
14,000
0.04% of shares
low
Jan 2, 2026Odrich Marc
Executive
GrantStock Option (right to buy)—+84K
84,200
0.27% of shares
low
Jan 2, 2026Olsson Shawn
Executive
GrantRestricted Stock Unit—+14K
14,000
0.04% of shares
low
Jan 2, 2026Olsson Shawn
Executive
GrantStock Option (right to buy)—+84K
84,200
0.27% of shares
low
Jan 2, 2026Schimmelpennink Evert B.
CEO
GrantStock Option (right to buy)—+358K
358,100
1.14% of shares
low
Jan 2, 2026Chevallard Daniel R.
Executive
GrantRestricted Stock Unit—+14K
14,000
0.04% of shares
low
Jan 2, 2026Chevallard Daniel R.
Executive
GrantStock Option (right to buy)—+84K
84,200
0.27% of shares
low
← PrevPage 1 of 1Next →